https://www.prnewswire.co.uk/news-releases/vapotherm-inc-announces-ce-mark-approval-for-flowrestr-homecare-device-156782875.html
Vapotherm, Inc. Announces CE Mark Approval for Flowrest(R) Homecare Device
/PRNewswire/ -- Vapotherm, the global leader in High Flow Therapy products, announced receiving CE marking for Flowrest(R), a device designed for homecare...
ce markvapothermincannounces
https://www.benzinga.com/general/biotech/23/09/34870546/vapotherms-asthma-therapy-more-effective-than-standard-oxygen-therapy-in-kids
Vapotherm's Asthma Therapy More Effective Than Standard Oxygen Therapy In Kids - Benzinga
Sep 25, 2023 - Vapotherm Inc (NASDAQ: VAPO) announced the presentation of an investigator-initiated clinical trial at the European Respiratory Society International Congress...
asthma therapymore effective
https://www.fool.com/earnings/call-transcripts/2019/05/14/vapotherm-inc-vapo-q1-2019-earnings-call-transcrip.aspx
Vapotherm Inc (VAPO) Q1 2019 Earnings Call Transcript | The Motley Fool
May 15, 2019 - VAPO earnings call for the period ending March 31, 2019.
earnings call transcriptthe motleyvapotherminc